August 5, 2020
Jeffrey Strawn, MD, teamed up with experts at Cincinnati Children's Hospital Medical Center to create an app to help children deal with anxiety caused by the pandemic.
February 9, 2021
Tesfaye Mersha, a geneticist at the University of Cincinnati and Cincinnati Children's Hospital Medical Center, says including African populations in genetics research is paving the way for a better understanding of the links between disease and genes in everyone, everywhere, because Africa holds more genomic diversity than any other continent.
January 22, 2021
Researchers at the University of Cincinnati have tested a new combination therapy in head and neck cancer animal models to see if they could find a way to make an already effective treatment even better.
December 11, 2020
Matthew de Gannes is one of 38 students in the College of Medicine who will earn degrees during the virtual 2020 fall commencement ceremonies set for Dec. 11 and 12. The college will grant 14 doctoral, 23 master’s and one bachelor’s degree. UC is awarding a total of 2,457 degrees to 2,348 students during fall commencement. Some UC programs allow students to earn dual degrees.
June 8, 2022
Immersion innovation is ‘triple winner’ when it comes to current and future patient care, student career options and readiness, and as a means to help close healthcare workforce gaps
February 7, 2023
The National Cancer Institute (NCI) has announced an intent to fund research from the University of Cincinnati’s Andrew Waters, PhD, to better understand how to overcome treatment resistance and develop better treatments for KRAS-mutated pancreatic cancer.
April 12, 2022
The University of Cincinnati's Kyle Wang, MD, is the site principal investigator for the Trident trial, studying the effectiveness of earlier electrical treatment through Optune devices to treat glioblastomas.
November 7, 2022
The University of Cincinnati is part of a multimillion-dollar grant from the National Heart, Lung, and Blood Institute to study a strategy to prevent stroke in patients with atrial fibrillation. The trial will incorporate the use of an app on Apple Watch to monitor an irregular heartbeat to reduce patients’ reliance on blood-thinning medication.
October 20, 2022
New research out of the University of Cincinnati shows that a course of a hepatitis B vaccine provides complete protection for people with HIV. The UC research shows that a three-dose course of the hepatitis B vaccine HEPLISAV-B provides complete protection for people living with HIV who have never been vaccinated against or exposed to the hepatitis B virus (HBV).
October 17, 2022
Treatments for pulmonary arterial hypertension (PAH) — a type of high blood pressure that affects arteries in the lungs and in the heart — have improved significantly over the past 15 to 20 years and researchers at the University of Cincinnati have been at the forefront of those improvements. The result of a series of studies UC researchers were part of have allowed new medications to come to market for patients with PAH.